We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LI:NASDAQLi Auto Inc. Analysis

Data as of 2026-05-23 - not real-time

$15.89

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Li Auto is trading at $15.89, well under its 20‑day (≈$17.72) and 50‑day (≈$17.95) simple moving averages, signaling a bearish price environment. The RSI of 33.8 hints at oversold conditions, while a bearish MACD histogram reinforces downside momentum, even as volume is trending higher. On the fundamentals side, the stock carries a trailing P/E of roughly 99× but a forward P/E near 19×, suggesting the current price may be discounted relative to upcoming earnings. However, the company posted a 35% revenue decline, negative operating cash flow, and a high debt‑to‑equity ratio (>24), raising concerns about cash sustainability.
The launch of the all‑new Li L9 on May 17 adds a fresh catalyst, potentially expanding the premium EV lineup and supporting the analyst consensus “Buy” with a median target of $19.48 and a mean target of $21.17, implying ~33% upside. Yet, extreme market greed (Fear‑Greed Index 91.6) and a 46% 30‑day volatility underscore a volatile trading backdrop. Investors must weigh the short‑term technical weakness against the longer‑term growth narrative in China’s EV sector.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below key moving averages and bearish MACD
  • New Li L9 launch could provide near‑term catalyst
  • High 30‑day volatility and negative cash flow

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E ~19× suggests valuation compression
  • Analyst price targets imply ~30% upside
  • Expansion of premium EV portfolio with L9

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term growth of China’s EV market
  • Potential improvement in margins as scale improves
  • Strategic positioning as a premium smart EV brand

Key Metrics & Analysis

Financial Health

Revenue Growth-35.00%
Profit Margin1.00%
P/E Ratio99.3
ROE1.58%
ROA-0.17%
Debt/Equity24.36
P/B Ratio1.5
Op. Cash Flow$-8611396608
Free Cash Flow$-11210257408

Technical Analysis

TrendBearish
RSI33.8
Support$15.40
Resistance$20.09
MA 20$17.72
MA 50$17.95
MA 200$19.68
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Target Price$21.17
Upside/Downside33.22%
GradeFair
TypeBlend

Risk Assessment

Beta0.97
Volatility46.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.